Abstract:BACKGROUND: Protective CD4+CD25+ regulatory T cells bearing the Forkhead Foxp3 transcription factor can now be divided into three subsets: Endogenous thymus-derived cells, those induced in the periphery, and another subset induced ex-vivo with pharmacological amounts of IL-2 and TGF-β. Unfortunately, endogenous CD4+CD25+ regulatory T cells are unstable and can be converted to effector cells by pro-inflammatory cytokines. Although protective Foxp3+CD4+CD25+ cells resistant to proinflammatory cytokines have been generated in mice, in humans this result has been elusive. Our objective, therefore, was to induce human naïve CD4+ cells to become stable, functional CD25+ Foxp3+ regulatory cells that were also resistant to the inhibitory effects of proinflammatory cytokines. METHODOLOGY/PRINCIPAL FINDINGS: The addition of the vitamin A metabolite, all-trans retinoic acid (atRA) to human naïve CD4+ cells suboptimally activated with IL-2 and TGF-β enhanced and stabilized FOXP3 expression, and accelerated their maturation to protective regulatory T cells. AtRA, by itself, accelerated conversion of naïve to mature cells but did not induce FOXP3 or suppressive activity. The combination of atRA and TGF-β enabled CD4+CD45RA+ cells to express a phenotype and trafficking receptors similar to natural Tregs. AtRA/TGF-β-induced CD4+ regs were anergic and low producers of IL-2. They had potent in vitro suppressive activity and protected immunodeficient mice from a human-anti-mouse GVHD as well as expanded endogenous Tregs. However, treatment of endogenous Tregs with IL-1β and IL-6 decreased FOXP3 expression and diminished their protective effects in vivo while atRA-induced iTregs were resistant to these inhibitory effects. CONCLUSIONS/SIGNIFICANCE: We have developed a methodology that induces human CD4(+) cells to rapidly become stable, fully functional suppressor cells that are also resistant to proinflammatory cytokines. This methodology offers a practical novel strategy to treat human autoimmune diseases and prevent allograft rejection without the use of agents that kill cells or interfere with signaling pathways.

Cutting Edge: Inhibition of Glycogen Synthase Kinase 3 Activity Induces the Generation and Enhanced Suppressive Function of Human IL-10+ FOXP3+–Induced Regulatory T Cells

TGF-β–Induced Regulatory T Cells Directly Suppress B Cell Responses Through a Noncytotoxic Mechanism

Glycogen synthase kinase 3β inhibition promotes human iTreg differentiation and suppressive function

Identification and Characterization of Foxp3+ Γδ T Cells in Mouse and Human

The Role of STAT3 in Antigen-Igg Inducing Regulatory CD4+Foxp3+T Cells

A Cellular MicroRNA Facilitates Regulatory T Lymphocyte Development by Targeting the FOXP3 Promoter TATA-Box Motif.

Foxp3-expressing CD4+T Cells under the Control of IFN-γ Promoter Prevent Diabetes in NOD Mice

Suppressive treg cell activity is potentiated by glycogen synthase kinase 3 β inhibition

Phenotypic and Functional Characteristic of Newly Identified CD8+Foxp3-CD103+ Regulatory T Cells (P1047)

Neutralization of IL-4 and IFN-γ Facilitates Inducing TGF-β-induced CD4(+)Foxp3(+) Regulatory Cells.

Characteristics of CD8+CD25- cells induced to become suppressor cells ex-vivo with IL-2 and TGF-β (89.34)

TGF-β Induces Foxp3 + T-Regulatory Cells from CD4 + CD25 − Precursors

Characterization of Protective Human CD4CD25 FOXP3 Regulatory T Cells Generated with IL-2, TGF-β and Retinoic Acid.

Targeted Demethylation of FOXP3-TSDR Enhances the Suppressive Capacity of STAT6-deficient Inducible T Regulatory Cells

Epigenetically Modifying the Foxp3 Locus for Generation of Stable Antigen-Specific Tregs As Cellular Therapeutics

Suppression of FOXP3 expression by the AP-1 family transcription factor BATF3 requires partnering with IRF4

Suppressive Regulatory T Cell Activity Is Potentiated By Glycogen Synthase Kinase 3 Beta Inhibition

Phenotypic and Functional Characteristic of a Newly Identified CD8+ Foxp3- CD103+ Regulatory T Cells.

ICOS Signal Facilitates Foxp3 Transcription to Favor Suppressive Function of Regulatory T Cells.

Cutting Edge: Foxp3(+)Cd4(+)Cd25(+) Regulatory T Cells Induced by Il-2 and Tgf-Beta Are Resistant to Th17 Conversion by Il-6

Synergy Between IL-6 and TGF-β Signaling Promotes FOXP3 Degradation.